HUMAN PAPILLOMA VIRUS
Clinical trials for HUMAN PAPILLOMA VIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMA VIRUS trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMA VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation cut by more than half in new throat cancer trial
Disease control Recruiting nowThis study is testing whether a much lower dose of radiation, combined with standard chemotherapy, can effectively control HPV-positive throat cancer while causing fewer side effects. It will involve 121 adults with this specific cancer type who have not had prior radiation to th…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Yale tests drug combo for rare, recurring throat and lung growths
Disease control Recruiting nowThis early-phase study is testing whether a combination of two existing cancer drugs can help control a rare condition where HPV causes recurring wart-like growths in the airways and lungs. The trial will enroll about 20 adults to see if the drugs are safe and can shrink the grow…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New combo therapy aims to shrink tumors, cut harsh treatment for HPV-Linked throat cancer
Disease control Recruiting nowThis study is testing whether adding two new, experimental drugs (HB-201 and HB-202) to standard chemotherapy can better shrink tumors in people with HPV16-positive throat cancer. The goal is to see if this stronger initial treatment allows doctors to safely use less radiation or…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Home HPV test kits aim to reach women missing vital cancer screenings
Diagnosis Recruiting nowThis study is testing whether two different at-home HPV self-collection kits are a good alternative to a doctor's Pap smear for cervical cancer screening. It focuses on helping minority women aged 25-65 who have fallen behind on their screenings, often due to barriers like langua…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Mar 27, 2026 12:39 UTC
-
New push to boost HPV vaccine rates in Hard-to-Reach communities
Prevention Recruiting nowThis study is testing whether a special educational program can help more young people and their parents in underserved communities get the full series of HPV vaccines. The program uses videos and informational materials to explain HPV, related cancers, and the importance of vacc…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Prevention
Last updated Apr 01, 2026 23:26 UTC
-
Could fewer shots protect women with HIV from cancer?
Prevention Recruiting nowThis study is testing whether two doses of the HPV vaccine work as well as the standard three doses for women living with HIV. The goal is to prevent HPV infection and the cervical cancer it can cause. Researchers will compare the immune response in women who get two shots versus…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: PHASE4 • Sponsor: University of British Columbia • Aim: Prevention
Last updated Mar 27, 2026 12:37 UTC
-
Fast HPV test could revolutionize cervical cancer prevention in developing world
Prevention Recruiting nowThis study aims to prevent cervical cancer by testing a new, faster screening strategy in Honduras. It will evaluate a self-collected HPV test that gives results in under an hour, allowing for potential same-day treatment of pre-cancerous cells. The goal is to see if this approac…
Matched conditions: HUMAN PAPILLOMA VIRUS
Sponsor: Atila Biosystems Inc. • Aim: Prevention
Last updated Mar 25, 2026 14:08 UTC